[Continuous dopaminergic stimulation in Parkinson disease]

Impact of a perioperative protocol for Parkinson's disease patients on use of contraindicated drugs.

Neurologia·2026

Differential pathological dynamics triggered by distinct Parkinson patient-derived α-synuclein extracts in nonhuman primates.

Science advances·2025

Nigrostriatal iron accumulation in the progression of Parkinson's disease.

NPJ Parkinson's disease·2025

Microvascular decompression for trigeminal neuralgia: A retrospective analysis of long-term outcomes and prognostic factors.

Neurologia·2023

Dopaminergic denervation and associated MRI microstructural changes in the nigrostriatal projection in early Parkinson's disease patients.

NPJ Parkinson's disease·2023

Spanish expert consensus on the use of safinamide in Parkinson's disease.

Neurologia·2021

[Neurological complications in critical patients with COVID-19].

Neurologia (Barcelona, Spain)·2024

[Relation between COVID-19 and Guillain-Barré syndrome in adults. Systematic review].

Neurologia (Barcelona, Spain)·2024

[Three-month functional prognosis of patients hospitalised due to acute ischaemic stroke in Aragon: Rregional analysis of the impact of COVID-19].

Neurologia (Barcelona, Spain)·2024

[Smell and taste disorders in Spanish patients with mild COVID-19].

Neurologia (Barcelona, Spain)·2024

[Standard headache and neuralgia treatments and SARS-CoV-2: opinion of the Spanish Society of Neurology's Headache Study Group].

Neurologia (Barcelona, Spain)·2024

[Case fatality of COVID-19 in patients with neurodegenerative dementia].

Neurologia (Barcelona, Spain)·2024

Evaluation of brexpiprazole as adjunctive therapy in treatment-resistant depression: Real-world data.

Dusunen adam : Bakirkoy Ruh ve Sinir Hastaliklari Hastanesi yayin organi·2026

Unveiling the sumatriptan dose-relief relationship.

European journal of clinical pharmacology·2026

Comparison of Trough-Only and Peak-Trough Concentration Data for the Calculation of Vancomycin Area under the Concentration-Time Curve on Day 2 Using Previous and Updated Population Pharmacokinetic Models.

Biological & pharmaceutical bulletin·2026

Mapping Therapeutic Drug Monitoring Research in Low- and Middle-Income Countries: A Scoping Review (2015-2024).

Therapeutic drug monitoring·2026

Polymeric systems for peptide and protein delivery: design principles, translational barriers, and future research directions.

International journal of pharmaceutics·2026

Safety, tolerability, and efficacy of flexible-dose tavapadon for Parkinson's disease (TEMPO-2): a phase 3, randomised, placebo-controlled, double-blind trial.

The Lancet. Neurology·2026

Related Experiment Videos

[Continuous dopaminergic stimulation in Parkinson disease]

Related Concept Videos

Impact of a perioperative protocol for Parkinson's disease patients on use of contraindicated drugs.

Differential pathological dynamics triggered by distinct Parkinson patient-derived α-synuclein extracts in nonhuman primates.

Nigrostriatal iron accumulation in the progression of Parkinson's disease.

Microvascular decompression for trigeminal neuralgia: A retrospective analysis of long-term outcomes and prognostic factors.

Dopaminergic denervation and associated MRI microstructural changes in the nigrostriatal projection in early Parkinson's disease patients.

Spanish expert consensus on the use of safinamide in Parkinson's disease.

[Neurological complications in critical patients with COVID-19].

[Relation between COVID-19 and Guillain-Barré syndrome in adults. Systematic review].

[Three-month functional prognosis of patients hospitalised due to acute ischaemic stroke in Aragon: Rregional analysis of the impact of COVID-19].

[Smell and taste disorders in Spanish patients with mild COVID-19].

[Standard headache and neuralgia treatments and SARS-CoV-2: opinion of the Spanish Society of Neurology's Headache Study Group].

[Case fatality of COVID-19 in patients with neurodegenerative dementia].

Evaluation of brexpiprazole as adjunctive therapy in treatment-resistant depression: Real-world data.

Unveiling the sumatriptan dose-relief relationship.

Comparison of Trough-Only and Peak-Trough Concentration Data for the Calculation of Vancomycin Area under the Concentration-Time Curve on Day 2 Using Previous and Updated Population Pharmacokinetic Models.

Mapping Therapeutic Drug Monitoring Research in Low- and Middle-Income Countries: A Scoping Review (2015-2024).

Polymeric systems for peptide and protein delivery: design principles, translational barriers, and future research directions.

Safety, tolerability, and efficacy of flexible-dose tavapadon for Parkinson's disease (TEMPO-2): a phase 3, randomised, placebo-controlled, double-blind trial.

Related Experiment Videos

[Continuous dopaminergic stimulation in Parkinson disease]

Related Concept Videos

Related Articles